[Is it necessary to perform a surgery after neo-adjuvant treatment for initially borderline or locally advanced pancreatic adenocarcinoma?]

Bull Cancer. 2015 Jun;102(6 Suppl 1):S111-2. doi: 10.1016/S0007-4551(15)31229-7.

[Article in French]

Authors

Thierry André¹, François Paye²

Affiliations

¹ Service d'oncologie médicale, Hôpitaux universitaires de l'Est Parisien (AP-HP), Site Saint-Antoine 184, rue du Faubourg Saint-Antoine, 75571 Paris cedex 12; UPMC Paris 6, France. Electronic address: thierry.andre@sat.aphp.fr.
² Service de chirurgie digestive et hépatobiliaire, Hôpitaux universitaires de l'Est Parisien (AP-HP), Site Saint-Antoine 184, rue du Faubourg Saint-Antoine, 75571 Paris cedex 12; UPMC Paris 6, France.

PMID: 26118868
DOI: 10.1016/S0007-4551(15)31229-7

No abstract available

MeSH terms

Adenocarcinoma / blood supply
Adenocarcinoma / pathology
Adenocarcinoma / therapy*
Antineoplastic Agents / therapeutic use
Diagnostic Imaging
Humans
Neoadjuvant Therapy*
Pancreatic Neoplasms / blood supply
Pancreatic Neoplasms / pathology
Pancreatic Neoplasms / therapy*

Substances

Antineoplastic Agents